Assessment of disease progression in systemic sclerosis-associated interstitial lung disease (SSc-ILD) patients using Functional Respiratory Imaging (FRI)
J. Clukers (Antwerp, Belgium), K. Homer (Ann Arbor, United States of America), M. Lanclus (Los Angeles, United States of America), D. Belmans (Kontich, Belgium), C. Van Holsbeke (Kontich, Belgium), W. De Backer (Antwerp, Belgium), J. De Backer (Los Angeles, United States of America), D. Khanna (Ann Arbor, United States of America)
Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Clukers (Antwerp, Belgium), K. Homer (Ann Arbor, United States of America), M. Lanclus (Los Angeles, United States of America), D. Belmans (Kontich, Belgium), C. Van Holsbeke (Kontich, Belgium), W. De Backer (Antwerp, Belgium), J. De Backer (Los Angeles, United States of America), D. Khanna (Ann Arbor, United States of America). Assessment of disease progression in systemic sclerosis-associated interstitial lung disease (SSc-ILD) patients using Functional Respiratory Imaging (FRI). 4805
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: